UXN Co (XKRX:337840) EBIT : ₩ Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is UXN Co EBIT?

UXN Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was ₩2,330.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. UXN Co's annualized ROC % for the quarter that ended in Dec. 2024 was -9.94%. UXN Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 54.06%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

UXN Co EBIT Historical Data

The historical data trend for UXN Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

UXN Co EBIT Chart

UXN Co Annual Data

Trend

Dec22

Dec23

Dec24

EBIT

-1,496.26

-11,959.22

2,330.31

UXN Co Semi-Annual Data
	Dec22	Dec23	Dec24
EBIT	-1,496.26	-11,959.22	2,330.31

Competitive Comparison of UXN Co's EBIT

For the Medical Devices subindustry, UXN Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

UXN Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, UXN Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where UXN Co's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

UXN Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₩ Mil.

UXN Co (XKRX:337840) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

UXN Co's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

	ROC % (Q: Dec. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Dec. 2024 ))	/ count )
=	-5805.057 * ( 1 - 0% )	/	( (59300.943	+	57523.871)	/ 2 )
=	-5805.057	/	58412.407
=	-9.94 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	33395.981	-	478.285	-	( 24800.474	-	max(0, 51728.34	-	25345.093	+	24800.474	))
=	59300.943

	Invested Capital		(Q: Dec. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	29858.644	-	234.257	-	( 19652.221	-	max(0, 48178.148	-	20278.664	+	19652.221	))
=	57523.871

Note: The Operating Income data used here is one times the annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

UXN Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Dec. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	2330.308	/	( ( (4452.347 + max(-47676.883, 0))	+	(4169.45 + max(-43241.323, 0)) )	/	2 )
=	2330.308	/	( ( 4452.347	+	4169.45 )	/	2 )
=	2330.308	/	4310.8985
=	54.06 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(57.849	+	45	+	258.562)	-	(478.285	+	0	+	47560.009)
=	-47676.883

	Working Capital		(Q: Dec. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	45	+	267.833)	-	(234.257	+	0	+	43319.899)
=	-43241.323

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

UXN Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2024 )
	=		/	17958.204
	=	%

UXN Co EBIT Related Terms

Thank you for viewing the detailed overview of UXN Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

UXN Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » UXN Co Ltd (XKRX:337840) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 614, No. 1, 379, Green-ro, Jeollanam-do, Naju, KOR, 58325

Website

http://www.uxn.co.kr

UXN Co Ltd is a medical device company. It is engaged in the production of Blood glucose sensors, and blood glucose meter.

UXN Co Headlines

No Headlines